GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

1
Player Avatar marinalee (< 20) Submitted: 8/22/2007 5:32:09 AM : Outperform Start Price: $18.49 GTXI Score: -78.64

ready for the gate

Featured Broker Partners


Advertisement